JOHNSON & JOHNSON is 762.2x more valuable than Jade Biosciences, Inc. by market capitalization ($574.10 B vs $753.23 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | JBIO | JNJ |
|---|---|---|
| Market cap | $753.23 M | $574.10 B |
| US-listed rank | #2663 | #20 |
| Revenue (latest FY) | - | $94.19B |
| Net income (latest FY) | -$127.41M | $26.80B |
| Net margin | - | 28.5% |
| P/E (trailing FY) | - | 21.4 |
| SEC filings | 479 | 984 |
JOHNSON & JOHNSON is 762.2x more valuable than Jade Biosciences, Inc. by market capitalization ($574.10 B vs $753.23 M).
Full pages: Jade Biosciences, Inc. and JOHNSON & JOHNSON, or browse the full rankings.